New and effective treatments for nonmetastatic (nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC) are improving quality of life and survival for men with this common malignancy. Selection of treatment is contingent on safety and efficacy, patient factors and preferences, and potential adverse events. In this activity, an expert in prostate cancer provides guidance on selection of treatment pathways for three different patient presentations. The important role of shared decision making, including matching patient attributes with treatment side effect profiles, is also addressed to improve adherence to therapies and help optimize clinical outcomes.
Case studies with interactive benchmarking
To improve the quality of care for patients with nmCRPC and mCRPC
After completing this activity, participants should be better able to:
- Identify the appropriate use in clinical practice of newly approved treatment strategies for nmCRPC
- Evaluate regimens for the treatment of mCRPC based on current evidence, guidelines, and patient factors
- Apply strategies to improve the recognition and management of toxicities and challenges to patient
Oncology NPs, PAs, and nurses
CNE Credit Designation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
PA Planner: Jessica Garner, MMS, PA-C
AAPA Credit Designation Statement
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until January 31, 2020. PAs should only claim credit commensurate with the extent of their participation.
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from Astellas Pharma Global Development, Inc. and Sanofi Genzyme.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Continuing Education Alliance, Practicing Clinicians Exchange, the AAPA, or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Continuing Education Alliance are required to disclose to the audience any significant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Ms. Sims has no relevant financial relationships to disclose.
The Planning Committee for this activity included Jessica Garner, MMS, PA-C, of the University of the Pacific; Ruth Cohen, Warren Beckman, and Stephanie Stendardo of Continuing Education Alliance. The members of the Planning Committee have no relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the activity in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form online
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hours.
Release date: January 31, 2019
Expiration date: January 31, 2020
© 2020 Practicing Clinicians Exchange. All Rights Reserved. APCE95418